Teva CEO Kare Schultz: We’re on track for financial goals
Several years ago, Teva Pharmaceuticals Industries (TASE: TEVA; NYSE: TEVA) set three long-term financial goals for itself: an operating profit margin of 28%; a cash:profit ratio of over 80%; and…